HIgh Power short duration radiofrequency ablation or cryoballoon ablation for paroxysmal Atrial Fibrillation (HIPAF trial)
In this randomized non-inferiority trial comparing vHPSD RFA to CBA for PVI in patients with PAF, non-inferiority of vHPSD RFA could not be shown. Both methods showed comparable safety outcome with a shorter procedure time for CBA.
Authors
- C Scheurlen (ORCID: https://orcid.org/0000-0001-7054-3535)
- Daniel Steven (ORCID: https://orcid.org/0000-0001-6839-5895)
- Kerstin Daniela Rosenberger (ORCID: https://orcid.org/0000-0003-3459-3812)
- James J. Ackmann (ORCID: https://orcid.org/0000-0002-9942-0368)
- Jonas Wörmann (ORCID: https://orcid.org/0000-0002-2213-8946)
- Karlo Filipovic
- Jakob Lüker (ORCID: https://orcid.org/0000-0003-4667-2200)
- Stephanie Kreutzer
- Jan‐Hendrik Schipper (ORCID: https://orcid.org/0000-0003-0208-3295)
- Jan‐Hendrik van den Bruck (ORCID: https://orcid.org/0000-0003-0468-4887)
- Arian Sultan (ORCID: https://orcid.org/0000-0003-1807-4860)
Institutions
- University of Cologne (DE)
- Asklepios Klinik St. Georg (DE)
- University Hospital Cologne (DE)
Publication Details
- Journal
- EP Europace
- Published
- 2025-03-31
- DOI
- https://doi.org/10.1093/europace/euaf066
- Citations
- 3
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 4.16